Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery

Study Purpose

Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients treated with minimally invasive approach, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery rates, and the role of standard work to improve patient outcomes and reduce surgical and postoperative complications.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

1. >18 years of age at the time of treatment 2. Diagnosis of adult congenital, degenerative, idiopathic, neuromuscular, inflammatory or iatrogenic spinal deformity 3. EOS full body or standing 36" AP & Lateral images of entire spine 4. Surgery to be schedule to take place within 6 months (otherwise PROMs/Radiographic images to be recollected) 5. Surgery to include > 3 levels percutaneous posterior spinal instrumentation or 3 level stand-alone lateral 6. And any one of the following: a. Radiographic criteria incorporating percutaneous posterior spinal instrumentation: i. PI-LL ≥ 25 degrees ii. Thoracolumbar/lumbar scoliosis ≥ 20 degrees iii. SVA >10cm iv. PT > 30 b. Procedural criteria: i. Single-position surgery ≥ 3 levels fused (Levels=vertebra; S1 is counted as a level; S2 &/or pelvis/ilium is not) ii. Staged ≥ 3 levels fused with percutaneous pedicle screws iii. 3 column osteotomy with percutaneous fixation iv. ACR incorporating open or percutaneous fixation.

Exclusion Criteria:

1. Deformity due to acute trauma. 2. Active spine tumor or infection. 3. Patient is unwilling or unable to complete questionnaires. 4. Women who are pregnant. 5. Prisoners -

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT04885244
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

International Spine Study Group Foundation
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Praveen Mummaneni, MDPaul Park, MDGregory Mundis, MDJuan Uribe, MD
Principal Investigator Affiliation University of San FranciscoUniversity of MichiganScripps Clinic, Department of Orthopedic Surgery, La Jolla, CABarrow Neurological Institute, Phoenix, AZ
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other, Industry
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Adult Spinal Deformity, Scoliosis, Kyphosis, Sagittal Imbalance
Additional Details

Specific Aims:

  • - Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients treated with minimally invasive approach, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery rates, and the role of standard work to improve patient outcomes and reduce surgical and postoperative complications.
a. Complex ASD patients will be defined based upon clinical, radiographic and/or procedural criteria.
  • - Develop and validate a standardized, universal complications classification system for minimally invasive spine surgery.
  • - Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for minimally invasive adult spinal deformity surgery.
  • - Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including Scoliosis Research Society 22r (SRS 22r) modified Oswestry Disability Index (mODI), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS), and patient reported outcome measurement information system (PROMIS).
  • - Evaluate clinical outcomes stratifying by patient chronological and physiological age.
  • - Evaluate the cost for episode of care for minimally invasive CADS surgery and cost per QALY gain compared to open surgery for CADS.
  • - Evaluate the contribution of patient frailty to patient outcomes, cost of care, disability, and complications.
  • - Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients treated with MIS techniques, and establish best practice guidelines for assessing MH.
  • - Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for MIS ASD surgery.
  • - Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for MIS ASD surgery and risk factors for routine (home) discharge vs.#46; skilled nursing facility (SNF)/rehabilitation facility.
  • - Broaden the evaluation of the minimally invasive surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications.
  • - Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for minimally invasive surgical treatment of ASD.
  • - Evaluate the use of robotic techniques in minimally invasive spine surgery for ASD, and its impact on radiographic parameters and clinical outcomes.
  • - Evaluate the use of expandable cages in minimally invasive spine surgery for ASD, and its impact on radiographic parameters and clinical outcomes.
  • - Evaluate the OR efficiency, morbidity of surgery, and cost per episode of care relating to single-position vs.#46; multi-position CADS surgery.
  • - Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.

Arms & Interventions

Arms

: Operative

Multicenter, prospective, nonrandomized analysis of ASD patients w/diagnosis of congenital, degenerative, idiopathic, neuromuscular, inflammatory or iatrogenic spinal deformity. Participants must be scheduled to have 3 or more levels of Percutaneous posterior spinal instrumentation or 3 level stand alone lateral surgery within next 6 months.

Interventions

Procedure: - Index or spine revision surgery for complex adult spinal deformity

Surgical interventions will be patient specified by treating surgeon.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Barrow Neurological Institute, Phoenix, Arizona

Status

Recruiting

Address

Barrow Neurological Institute

Phoenix, Arizona, 85013

Site Contact

Luke O'Neill

luke.o'[email protected]

6184444130

La Jolla, California

Status

Recruiting

Address

Shiley Center for Orthopaedic Research and Education at Scripps Clinic

La Jolla, California, 92037

Site Contact

Tina Iannacone, MPH

[email protected]

858-554-7124

Cedars-Sinai Medical Center, Los Angeles, California

Status

Recruiting

Address

Cedars-Sinai Medical Center

Los Angeles, California, 90048

Site Contact

Babak Khanderoo

[email protected]

6184444130

San Francisco, California

Status

Recruiting

Address

University of California - San Francisco Medical Center

San Francisco, California, 94143

Site Contact

Alysha Jamieson

[email protected]

6184444130

University of Miami, Miami, Florida

Status

Recruiting

Address

University of Miami

Miami, Florida, 33125

Site Contact

Adriana Saravia

[email protected]

6184444130

Chicago, Illinois

Status

Recruiting

Address

Rush University, Department of Neurosurgery

Chicago, Illinois, 60612

Site Contact

Reehan Malhance

[email protected]

6184444130

Louisiana Spine Institute, Shreveport, Louisiana

Status

Recruiting

Address

Louisiana Spine Institute

Shreveport, Louisiana, 71101

Site Contact

Brandi Casey

[email protected]

6184444130

Ann Arbor, Michigan

Status

Completed

Address

University of Michigan, Department of Neurosurgery

Ann Arbor, Michigan, 48109

New York, New York

Status

Recruiting

Address

Columbia University - New York-Presbyterian Och Spine Hospital

New York, New York, 10034

Site Contact

Vivian Le

[email protected]

6184444130

Duke University Health System, Durham, North Carolina

Status

Recruiting

Address

Duke University Health System

Durham, North Carolina, 27710

Site Contact

Ronald Pegues

[email protected]

6184444130

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Status

Recruiting

Address

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213

Site Contact

Jan Alicandro

[email protected]

6184444130

Semmes-Murphey, Memphis, Tennessee

Status

Recruiting

Address

Semmes-Murphey

Memphis, Tennessee, 38120

Site Contact

Olivia House

[email protected]

6184444130